BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24792163)

  • 1. Programmable DNA-binding proteins from Burkholderia provide a fresh perspective on the TALE-like repeat domain.
    de Lange O; Wolf C; Dietze J; Elsaesser J; Morbitzer R; Lahaye T
    Nucleic Acids Res; 2014 Jun; 42(11):7436-49. PubMed ID: 24792163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-binding proteins from marine bacteria expand the known sequence diversity of TALE-like repeats.
    de Lange O; Wolf C; Thiel P; Krüger J; Kleusch C; Kohlbacher O; Lahaye T
    Nucleic Acids Res; 2015 Nov; 43(20):10065-80. PubMed ID: 26481363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of TALE-DNA interactions suggests polarity effects.
    Meckler JF; Bhakta MS; Kim MS; Ovadia R; Habrian CH; Zykovich A; Yu A; Lockwood SH; Morbitzer R; Elsäesser J; Lahaye T; Segal DJ; Baldwin EP
    Nucleic Acids Res; 2013 Apr; 41(7):4118-28. PubMed ID: 23408851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and highly efficient construction of TALE-based transcriptional regulators and nucleases for genome modification.
    Li L; Piatek MJ; Atef A; Piatek A; Wibowo A; Fang X; Sabir JS; Zhu JK; Mahfouz MM
    Plant Mol Biol; 2012 Mar; 78(4-5):407-16. PubMed ID: 22271303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The last half-repeat of transcription activator-like effector (TALE) is dispensable and thereby TALE-based technology can be simplified.
    Zheng CK; Wang CL; Zhang XP; Wang FJ; Qin TF; Zhao KJ
    Mol Plant Pathol; 2014 Sep; 15(7):690-7. PubMed ID: 24521457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimerization Enables Gene Synthesis and Lentiviral Delivery of Customizable TALE-Based Effectors.
    Fang Y; Stroukov W; Cathomen T; Mussolino C
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A TAL effector repeat architecture for frameshift binding.
    Richter A; Streubel J; Blücher C; Szurek B; Reschke M; Grau J; Boch J
    Nat Commun; 2014 Mar; 5():3447. PubMed ID: 24614980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of custom TALE-type DNA binding domains by modular cloning.
    Morbitzer R; Elsaesser J; Hausner J; Lahaye T
    Nucleic Acids Res; 2011 Jul; 39(13):5790-9. PubMed ID: 21421566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat 1 of TAL effectors affects target specificity for the base at position zero.
    Schreiber T; Bonas U
    Nucleic Acids Res; 2014 Jun; 42(11):7160-9. PubMed ID: 24792160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly of designer TAL effectors by Golden Gate cloning.
    Weber E; Gruetzner R; Werner S; Engler C; Marillonnet S
    PLoS One; 2011; 6(5):e19722. PubMed ID: 21625552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription activator-like effectors: a toolkit for synthetic biology.
    Moore R; Chandrahas A; Bleris L
    ACS Synth Biol; 2014 Oct; 3(10):708-16. PubMed ID: 24933470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of Transcription Activator-Like Effectors in Xanthomonas oryzae.
    Erkes A; Reschke M; Boch J; Grau J
    Genome Biol Evol; 2017 Jun; 9(6):1599-1615. PubMed ID: 28637323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TALE: a tale of genome editing.
    Zhang M; Wang F; Li S; Wang Y; Bai Y; Xu X
    Prog Biophys Mol Biol; 2014 Jan; 114(1):25-32. PubMed ID: 24291598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.
    Cermak T; Doyle EL; Christian M; Wang L; Zhang Y; Schmidt C; Baller JA; Somia NV; Bogdanove AJ; Voytas DF
    Nucleic Acids Res; 2011 Jul; 39(12):e82. PubMed ID: 21493687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiplexed transcription activator-like effector system for detecting specific DNA sequences.
    Honarmand A; Mayall R; George I; Oberding L; Dastidar H; Fegan J; Chaudhuri S; Dole J; Feng S; Hoang D; Moges R; Osgood J; Remondini T; van der Meulen WK; Wang S; Wintersinger C; Zaparoli Zucoloto A; Chatfield-Reed K; Arcellana-Panlilio M; Nygren A
    ACS Synth Biol; 2014 Dec; 3(12):953-5. PubMed ID: 25524096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction.
    Doyle EL; Booher NJ; Standage DS; Voytas DF; Brendel VP; Vandyk JK; Bogdanove AJ
    Nucleic Acids Res; 2012 Jul; 40(Web Server issue):W117-22. PubMed ID: 22693217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.
    Mussolino C; Morbitzer R; Lütge F; Dannemann N; Lahaye T; Cathomen T
    Nucleic Acids Res; 2011 Nov; 39(21):9283-93. PubMed ID: 21813459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and DNA-binding specificities of Ralstonia TAL-like effectors.
    Li L; Atef A; Piatek A; Ali Z; Piatek M; Aouida M; Sharakuu A; Mahjoub A; Wang G; Khan S; Fedoroff NV; Zhu JK; Mahfouz MM
    Mol Plant; 2013 Jul; 6(4):1318-30. PubMed ID: 23300258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locked and proteolysis-based transcription activator-like effector (TALE) regulation.
    Lonzarić J; Lebar T; Majerle A; Manček-Keber M; Jerala R
    Nucleic Acids Res; 2016 Feb; 44(3):1471-81. PubMed ID: 26748097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breaking the DNA-binding code of Ralstonia solanacearum TAL effectors provides new possibilities to generate plant resistance genes against bacterial wilt disease.
    de Lange O; Schreiber T; Schandry N; Radeck J; Braun KH; Koszinowski J; Heuer H; Strauß A; Lahaye T
    New Phytol; 2013 Aug; 199(3):773-86. PubMed ID: 23692030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.